13 July 2012
Smith & Nephew plc (LSE: SN, NYSE: SNN), the global medical technology business, will announce its results for the second quarter and half year ended 30 June 2012 on Thursday 2 August 2012 at 7.00am BST/2.00am Eastern time. This will be followed by a conference call for financial analysts at 8.30am BST/3.30am Eastern time, which can be heard live via audio webcast on the Smith & Nephew website at www.smith-nephew.com and available on the site archive shortly afterwards.
About Us
Smith & Nephew is a global medical technology business dedicated to helping improve people's lives. With leadership positions in Orthopaedic Reconstruction, Advanced Wound Management, Sports Medicine and Trauma, Smith & Nephew has almost 11,000 employees and a presence in more than 90 countries. Sales in 2011 were nearly $4.3 billion. Smith & Nephew is a member of the FTSE100 (LSE: SN, NYSE: SNN).
Enquiries:
Investors/Analysts |
|
Kim Gunthorp |
Tel: +44 (0) 207 401 7646 |
Smith & Nephew plc |
|
|
|
Media |
|
Charles Reynolds Smith & Nephew plc
Justine McIlroy Brunswick - London |
Tel: +44 (0) 207 401 7646
Tel: +44 (0) 207 404 5959 |
|
|